Understanding the commercialization of pluripotent stem cell technologies in Sweden

While Sweden has a strong international position in PSC science, translating this excellence into scalable advanced therapy medicinal products (ATMPs) and sustainable commercial outcomes remains a systemic challenge. The workshop addressed this gap through an innovation ecosystem perspective, examining how scientific, clinical, industrial, regulatory, and financial capacities interact—and where coordination breaks down.

 

Building on a data‑driven mapping of the Swedish PSC landscape, the workshop was designed as a collective sense‑making exercise grounded in extensive ecosystem research conducted by

Dr. Yotam Sofer (Postdoctoral Researcher and Wallenberg Research Fellow),

Professor Valentina Tartari (Jacob and Marcus Wallenberg Professor of Innovative and Sustainable Business Development), and

Marthe‑Sarah (Research Assistant),

all at the House of Innovation, Stockholm School of Economics.

 

This work was carried out within the VR‑funded network “Pluripotent stem cell–derived cell therapy”, led by Professor Anna Falk (Lund University) as Principal Investigator.

 

The workshop convened participants from leading organizations across the Swedish life science and ATMP ecosystem, including Lund University, Karolinska Institutet, AstraZeneca, BioLamina, Nordic Cell Therapy Group, CCRM Nordic, SmartCella, Vertex Pharmaceuticals, and selected life science consultancies and scale‑up actors.

 

Through structured group discussions and plenary reflection, participants explored key commercialization bottlenecks, missing or weak complementary assets, and areas of latent potential. Rather than aiming for validation or consensus, the workshop surfaced diverse perspectives on what would be required for Sweden to position itself as a global leader in PSC‑based ATMPs.

 

Insights from the workshop continue to inform work within the VR network and contribute to forward‑looking reflections on the formation of a coordinated national ATMP cluster, with Sweden’s scientific strengths as a foundation for global leadership.